HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy	Bone Marrow Failure Disorders, Congenital Bone Marrow Failure Syndromes, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, DNA repair disease, Fanconi anemia, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, acute myeloid leukemia, anemia, aplastic anemia, bone marrow disorder, hematologic disorder, hereditary disease, inherited aplastic anemia, leukemia, metabolic disease, myelodysplastic syndrome, myelodysplastic syndrome with excess blasts, myelodysplastic syndrome with single lineage dysplasia, myeloid leukemia, neoplasm	Recruiting	Phase 2	2025-11-12		NCT02143830

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Children's Hospital Medical Center, Cincinnati	229
Fred Hutchinson Cancer Center	123
Memorial Sloan Kettering Cancer Center	753

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cincinnati Children's Hospital Medical Center	Cincinnati	United States	405
Fred Hutchinson Cancer Research Center	Seattle	United States	71
Memorial Sloan Kettering Cancer Center	New York	United States	2